Abstract: Selectivity for a target site is challenging when the site is conserved in homologous proteins. A novel protocol is presented for attaining selectivity by taking advantage of conformational population differences between homologs. Conformational ensembles of the targeted protein and the homolog are compared to identify pockets significantly populated in the target, but rarely or never sampled in the homolog. SLIDE screening then identifies molecules that fit the unique pocket and also interact well with an adjacent substrate pocket. The SpeciFlex protocol, demonstrated for a pair of pyrophosphokinases, yields ligand candidates with good interactions in both the substrate and unique pockets of the target Yersinia pestis protein, while selecting against interactions with the homologous site in Escherichia coli.
Introduction
Conformational selection. Conformational change occurs, to a greater or lesser extent, when all proteins and ligands form complexes. The rigid lock-and-key-fit model, with the protein as the lock and the ligand as the key, has been shown inadequate to model the transition between most ligand-free and bound protein structures, leading to a new focus on modeling molecular flexibility upon complex formation [1] [2] [3] [4] [5] [6] [7] [8] [9] . The conformational selection hypothesis [10] [11] , arising from energy landscape concepts in protein folding theory [12] [13] , describes the native state of the protein as sampling an ensemble of conformations between the ligand-free (open) and ligand-bound (closed) states. A ligand can select from this array of conformations and bias the equilibrium toward the catalytically competent or inhibitor-bound conformation. Several proteins have been shown to sample the conformations required for ligand binding as part of their native ensemble, including staphylococcal nuclease [14] [15] , calbindin [16] , adenylate kinase [17] [18] , and calmodulin [19] . A central concept here is that the energy required to shift the conformation of either the protein or ligand into the bound state becomes a penalty that decreases their affinity of interaction. Therefore, requiring an energetically expensive conformational change is unlikely.
Conformational differences as the basis for ligand selectivity. While the amino acids within binding sites tend to be highly conserved among structurally homologous proteins employing the same substrates and carrying out the same chemical reactions, near-closed conformations of these enzymes can differ. This is due to amino acid sequence variation that occurs near the binding site, particularly in binding-site loop side chains that face away from the site, which influence conformational sampling between the closed and open states. Furthermore, there is decreased evolutionary selection on these non-catalytic conformations. Statistical mechanics and the Boltzmann distribution tell us that the relative prevalence of conformations reflects their relative favorability in energy. Thus, for a targeted conformation to be useful as a template for discovering selective inhibitors, it is not necessary that the conformation be absolutely unique in the targeted protein relative to a homolog, but that it be well-sampled (low in energy) in the targeted protein and rarely sampled (much less favorable in energy) in the homolog.
A well-known example of selectivity gained by targeting a unique conformation is the cancer drug, Gleevec (imatinib), which was found by X-ray crystallography to bind to a unique, inactive kinase conformation, locking the activation loop. Closely related Src kinases cannot adopt this inactive conformation, allowing Gleevec to attain high selectivity for its target, Abl kinase [20] .
While this was a fortuitous discovery for Gleevec, the method presented here is designed to identify pockets conferring conformational selectivity, a priori. The search for ligands that selectively bind one protein relative to its homologs can then be directed towards the unique conformation.
We show that such conformations can be used as templates for SLIDE screening to discover ligands that are target-selective. While other screening methods such as FlexE [21] have also employed multiple protein conformations (typically from independent crystal structures) as input to docking and screening, and molecular dynamics analysis has been used to identify conformationally invariant regions as targets for drug discovery [22, 23] , the idea here is take advantage of differences in conformational occupancy sampled by protein dynamics as a way of enhancing target selectivity.
Biology of hydropterin pyrophosphokinases
This study focuses on the folate biosynthetic enzyme, 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK), a target for antibiotic development. Mammals use active transport for taking up folate compounds from their diets, while most microorganisms synthesize folates.
Thus, the folate biosynthetic pathway is one of the principal targets for developing antibiotics [24] . HPPK catalyzes the transformation of 6-hydroxymethyl dihydropterin to 6-hydroxymethyl dihydropterin pyrophosphate via the transfer of pyrophosphate from ATP. Here we focus on the identification of inhibitors specific to pathogenic Yersinia pestis HPPK, relative to the beneficial gastrointestinal bacterium, Escherichia coli. Y pestis is the causative agent of bubonic, pneumonic, and septicemic plague and one of the most virulent pathogens known [25] . Three recorded plague pandemics are estimated to have killed 200 million people [26] . The recent emergence of a multi-drug resistant strain of Y pestis, resistant to all first-line and several prophylactic antibiotics, is of particular concern [27] .
Our study begins with the crystallographic closed, ternary complexes of Y pestis and E coli HPPK bound to AMPCPP (an ATP analog in which the oxygen joining AMP to pyrophosphate is replaced by a non-hydrolyzable, single-bonded carbon), 6-hydroxymethy-7,8-dihydropterin (the other natural substrate), and two Mg 2+ ions, as deposited in Protein Data Bank [28] (PDB) entries 2QX0 and 1Q0N [29] [30] . There are only two amino acid differences between E coli and Y pestis HPPK near the targeted dihydropterin binding pocket. One is the E coli Tyr53 →Y pestis Phe difference, in which the hydrophobic contact made by these two side chains is conserved, and the hydroxyl group of the Tyr residue interacts with bulk solvent. The other is the E coli Pro43 →Y pestis Lys difference at the base of a binding site loop, with the side chain directed away from the dihydropterin. The result is that the dihydropterin pocket is highly conserved in closed structure and chemistry between the two species, providing no static differences that can be employed to attain inhibitor specificity. This makes the E coli and Y pestis dihydropterin sites in HPPK an ideal model system for exploring the use of conformational sampling differences as the basis for discovering species-selective inhibitors.
Experimental Methods
The SpeciFlex 1 protocol is divided into two steps: conformational analysis to identify a uniquely available pocket near the Y pestis dihydropterin site (Step 1, summarized in Figure 1 ) and virtual screening to identify compounds that interact well with the unique pocket in Y pestis but cannot interact similarly well with E coli (Step 2, summarized in Figure 2 ). In this particular application, compounds that also mimic dihydropterin interactions with Y pestis HPPK are sought, because ligand candidates that share interactions with known inhibitors have an enhanced probability of inhibition [31] . However, the method is entirely general and could be applied to the neighborhood of any known ligand pocket, or in fact to any binding cleft relevant to regulating protein activity (potentially an allosteric site). Following are details of the methods, which are cross-referenced by using the same step labels in the flowcharts (Figures 1 and 2 ).
The Results then show how these steps have been applied to HPPK to discover potential inhibitors that meet specific criteria for quality of interaction with the dihydropterin and unique pockets in Y pestis, while taking advantage of the differences in protein dynamics between species.
Step 1-1. Molecular dynamics conformational analysis of the protein target and its
homolog
The starting point for the SpeciFlex methodology (step 1-1, Figure 1 ) is the analysis of molecular dynamics trajectories that sample conformations near the substrate-bound, closed state of the binding site in the target protein as well as the off-target homolog. These trajectories can arise from molecular dynamics, elastic network models [32] , or methods like ROCK that sample dynamics consistent with maintaining a set of non-covalent interactions, e.g., those present in the closed structure [33] [34] . Given that any simulation method has sampling biases arising from the choice of potential energy function and parameterization of atoms and bonds, we chose to combine two simulation approaches: a fine-grained molecular dynamics simulation with explicit solvent, and a coarse-grained network model. By determining the consensus between the two dynamics trajectories in terms of volumes near the dihydropterin binding site available for ligand binding, the aim was to ensure that the identification of a pocket unique to the target protein remains robust with respect to variations in the way the dynamics are sampled.
Molecular dynamics analysis.
Explicit-solvent molecular dynamics trajectories were provided for Y pestis and E coli HPPK by colleagues Li Su and Robert Cukier (Department of Chemistry, Michigan State University), starting from the closed, ternary complexes (PDB entry 1Q0N for E coli and PDB entry 2QX0 for Y pestis) from which dihydropterin had been removed and AMPCPP was replaced by the native ATP, modeled using the GROMOS9644 force field [35] .
Using the Hamiltonian replica exchange method (HREM), replicas of the system that differed in potential energy terms were simulated concurrently, and system configurations were exchanged periodically. Three terms in the potential energy function had Lennard-Jones and electrostatic nonbonded interactions scaled differently between the replicas to enhance conformational sampling. These terms represented the potential energy of interactions (i) between atoms in loops 2 and 3, which close over the dihydropterin and ATP sites in HPPK, (ii) between a loop atom and an atom in the rest of the protein (largely a scaffold-like beta sheet structure), and (iii) between the atoms in the rest of the protein [35] . A small number of replicas were found to be as well as maintaining an average of 2.4 covalent + non-covalent interactions per atom, which is characteristic of the bond networks of the native states of proteins in general [38] .
Details of ROCK analysis. ROCK trajectories were defined using the following parameter settings, most of which govern the efficiency of sampling: ring cluster rotation ratio (percentage of bonds sampled in a given step): 10%; ring-cluster rotation limit (maximum rotation of any Step 1-2. Determine the relative occupancy/availability of volumes surrounding the binding site.
The HREM and ROCK trajectories of E coli and Y pestis HPPK were considered individually (as four cases), with a 0.5 Å grid placed over the superimposed trajectories. For each grid point, the percentage of the trajectory that a probe ligand atom of 1.4 Å radius could occupy grid points in or near the dihydropterin site (without interpenetrating the protein) was calculated.
The neighborhood of the dihydropterin site evaluated was within 10 Å of the position of dihydropterin in the closed crystal structure in the search for volumes available in Y pestis but not E coli HPPK. Isocontouring using OpenEye VIDA software was applied to the grid values to define surfaces encompassing volumes representing 0%, 25%, 50%, 75%, and 100% availability for ligand atoms from each trajectory. The trajectories were then combined for Y pestis and separately for E coli HPPK, to identify volumes that were accessible 0%, 25%, 50%, 75% or 100% or the time in both the ROCK and HREM trajectories for the target and homolog,
respectively. This presents a more stringent criterion for identifying an available (or disallowed) volume, since it had to be present in both dynamics trajectories.
Step 1-3. Identify pocket volumes that are uniquely available in the target protein, which can then be used for selective inhibitor screening.
The ideal case is when a volume near the known substrate (e.g., dihydropterin) site is available 100% of the time in the target protein but never available (0%) in the off-target homolog. Given the proteins' homology, however, it may be difficult to find volumes of meaningful size that meet Table 1 . When a pocket is rarely available (e.g., only 0.02% of the time), the penalty in ΔG for achieving such conformations becomes quite significant, about 5 kcal/mol. However, for a targeted conformation that is found in 20% of the population, the penalty in change in free energy to reach that conformation is less than 1 kcal/mol. Thus, it is reasonable to aim for a pocket that is present in 20-100% of the protein's conformations and is never or very rarely sampled (e.g., 0.02%) in the off-target homolog. This unique pocket can then targeted for inhibition along with a neighboring substrate pocket.
Step 1-4. Identify a representative structure as the template for virtual screening
All 2400 HREM and energy-minimized ROCK snapshots of the target protein were considered in the context of the unique volume and adjacent substrate site defined in the previous step. By cycling through the snapshots one by one using a computational script, the conformation was chosen that yielded no steric overlaps and provided the maximum number of favorable van der Waals contacts with the substrate and unique pocket volumes. This conformation was used as the target for selective virtual screening.
Step 2-1. Preparing the database of ligand candidates for virtual screening
All low-energy conformers of the lead-like compound [41] Step Given dockings that were free of steric overlap and interacted with both the pterin and unique pockets, the overall quality of docking was evaluated by atomistic semi-empirical protein-ligand scoring. SLIDE versions 3.0 and above include two-tiered scoring to identify the optimal binding mode of each molecule in the first step using OrientScore, and then predict the affinity of the docked molecule in a second step using AffiScore [44] . SLIDE 3 docking using OrientScore followed by one second of energy minimization with Szybki (OpenEye Scientific Software) has been found to perform as well as GOLD and Surflex (the closest competitors), and somewhat better than GLIDE, FlexX, DOCK, QXP, and FRED, in accurately re-docking ligands in 100 protein complexes; 51% of the ligands were docked to within 1 Å RMSD and 54% to within 1.5
Å RMSD [44] [45] . The AffiScore scoring function used to predict ΔGbinding by SLIDE had a linear correlation coefficient of 0.65 with the experimentally determined binding affinity values for 273 complexes, similar to the best method tested (XScore; [46] ), which had a linear correlation coefficient of 0.68 [44] . In discovery applications, SLIDE identified seven new classes of low to mid-micromolar inhibitors for the ATP binding site in asparaginyl-tRNA sythetase from the human parasite Brugia malayi, with a hit rate of 15% [50] ; 7 out of 45 compounds assayed were confirmed as inhibitors. Flexibility modeling in this system also helped explain why a series of long side-chain analogs of the top-scoring inhibitor proved to be selective for the Brugia target relative to its human homolog, despite the absence of amino acid differences within the binding pocket. In a thrombin inhibitor discovery collaboration, 5 out of 26 (19%) of the top-scoring soluble SLIDE compounds were found to inhibit human thrombin, with IC50 values in the midnanomolar to mid-micromolar range [31] . Thus, we anticipate a hit rate of 15-19% in SLIDE applications, though that may depend significantly on the enzyme, ligand database, and scoring approach.
For retaining the best candidates from the 22 million ZINC8 lead-like conformers, an affinity threshold was set following screening the first one-fifth of the database. Only those compounds with an AffiScore at least two standard deviations better than the mean score (≤-8.4 kcal/mol) were kept, upon docking to Y pestis HPPK.
Step 2-3. Select compounds that interact well with both the known substrate pocket and the adjacent unique pocket
Given that a large number of compounds (61,066) met all the above criteria (Figure 2) , and current affinity prediction scoring functions have mean errors of ~2 kcal/mol, additional criteria were considered for selecting inhibitors. Previous results [31] indicate that high-scoring molecules identified by SLIDE that were subsequently proven to inhibit thrombin tended to share many interactions with known inhibitors. Other groups have explored the same approach in terms of filtering dockings according to pharmacophore constraints [51, 52] . Conserved hydrogen-bond and salt bridge interactions provided the most discrimination. Thus, for HPPK, compounds were retained that formed ≥3 of the same hydrogen bonds as dihydropterin in the crystal structure of Y pestis HPPK (PDB entry 2QX0) and placed ≥1 atom in the unique pocket.
Step
2-4. Filter out compounds that interact similarly well (in any binding mode) with the substrate pocket of the off-target homolog
Compounds that bound well to Y pestis HPPK using the above criteria are virtually guaranteed to not bind in the same orientation to any conformation of E coli HPPK. This is because the unique pocket volume was absent in the E coli closed crystal structure and all its dynamics conformations. However, a compound could conceivably bind to E coli in a different conformation or orientation and still make good interactions with the dihydropterin pocket, diminishing its selectivity for Y pestis HPPK. Thus, any compounds that docked and formed ≥3
of the same hydrogen bonds as pterin in E coli HPPK (PDB entry 1Q0N) were filtered out.
Step 2-5. Prioritize these compounds according to the quality of their interactions with the substrate pocket and adjacent unique pocket in the target protein
Given the remaining limited number of compounds (337, in the case of the HPPK screen), all of these compounds could be assayed for inhibition and other biological activities. Alternatively, they can be prioritized further by other protein-ligand scoring functions (e.g., DrugScore, EON, or GOLD, as was performed in [31] ). This choice is typically based on the software available to the user and any background knowledge of which scoring function(s) work best for that protein family. Here, based on our prior experience, they were prioritized based on the: i) number of hydrogen bonds in common with a known ligand, dihydropterin [31] , ii) number of hydrogen bonds made in the adjacent unique pocket, and iii) total number of hydrogen bonds plus hydrophobic interactions in the unique pocket. These proved useful for focusing in on compounds exhibiting protein complementarity typical of what a structural biologist would expect to see in a protein-inhibitor complex. 
Results and Discussion

Molecular dynamics analysis. Sampling achieved by HREM MD analysis for E coli HPPK and
Defining a unique available volume to gain conformational selectivity for the target protein.
A unique volume to gain selectivity for Y pestis HPPK needed to be available a significant percentage of time, such that the energetic cost of opening the pocket volume was not significant, e.g., ~1 kcal/mol or less (Table 1 ). There are essentially three criteria to be considered when selecting a unique pocket volume neighboring the substrate site. It should be:
(i) able to accommodate several ligand atoms in a pocket that maximizes ligand interactions, (ii) significantly available over time as a function of the protein's dynamics, and (iii) unavailable or rarely available to ligand atoms in the off-target homolog. The trade-off between these factors is determined by the conformational dynamics of the two proteins being considered. Here, it was possible to select the shell of E coli HPPK that is entirely occupied in all the MD and ROCK conformers ( Figure 5 ), overlay the 25% available shell of Y pestis HPPK, and identify a volume subtended by these surfaces and adjacent to the dihydropterin binding site that could accommodate several atoms in Y pestis HPPK (Figure 6 ). In general, one would start with the 100% occupied volume in the off-target homolog, and overlay each available-volume surface in the target protein in turn (e.g., 100% available, 75% available, 25% available, etc.) until a significantly available pocket was identified neighboring the substrate site. If the criteria could not be met with the 100% occupied surface in the off-target homolog, one would consider a slightly less-occupied shell (e.g., 90%) along with the most-available shell in the target protein that provides a unique pocket. The difference in energy of opening the pocket between the two homologs must strongly favor the target protein, according to the criteria in Table 1 .
The Y pestis HPPK structure chosen for virtual screening was the one best complementing the surface contours of the unique and substrate-binding pockets. Based on scanning the 2000 MD snapshots, 400 ROCK snapshots, and the closed crystal structure of Y pestis HPPK, conformation 194 from the ROCK simulation was identified as optimal and used to derive a screening template for SLIDE. One set of key points was placed in the deepest part of the dihydropterin pocket (as described in the Experimental Methods), and the second set was defined as all template points within the unique Y pestis pocket. Docked molecules were required to match at least one template point in each set.
Screening for compounds matching the substrate and unique sites. The SLIDE screening run was designed to identify molecules that: i) docked into both the dihydropterin and unique volumes, ii) had predicted affinity scores at least 2 standard deviations above the mean score (determined by screening the first 20% of the ZINC lead-like compounds), and iii) made at least three hydrogen bonds in common with the dihydropterin substrate in Y pestis HPPK but not in the E coli pterin pocket. This third criterion (step 2-4 in Figure 2 ) involved evaluating ligand candidates against representatives from all MD and ROCK conformational clusters for E coli HPPK (including the closed structure), and was designed to rule out compounds that could bind well in a different mode to the dihydropterin pocket of E coli.
Top-ranking compounds identified by the SpeciFlex protocol. Of the 337 compounds meeting the above criteria, nineteen were found to make at least 4 hydrogen bonds in common with dihydropterin and at least one favorable interaction in the unique pocket of Y pestis HPPK.
Eleven of the nineteen formed at least one hydrogen bond in the unique pocket. To illustrate the quality of some of the top-ranked molecules resulting from the SpeciFlex protocol, five representative compounds are shown (Figure 7 ), all of which shared at least three hydrogen bonds with dihydropterin and made at least two favorable interactions in the unique pocket. It is hydrogen-bond acceptor-rich, yet substantially mimics dihydropterin sterically and places its hydrogen-bonding groups in similar positions. In the unique pocket (upper right), two hydrogen bonds are formed by a single hydroxyl group on the phenyl ring, with the other hydroxyl group interacting with solvent. This compound is toxic according to the ChEMBL database (https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL404515), causing morphological changes in human HMC1 cells [47] at 50 μM concentration, and it inhibits human cyclooxygenase 1 activity by 39% at 5 μM concentration [48] . Thus, it remains important to check high-ranking compounds from virtual screening for reported biological activities and absorption, distribution, metabolism, excretion, and toxicology properties before further testing. 
Conclusions
The SpeciFlex protocol described here consists of one set of steps for identifying a unique pocket in the target protein relative to its homolog based on differential protein dynamics, and a second set of steps for using this information to screen for inhibitor candidates that complement the unique pocket and a neighboring substrate site. Results show that the resulting highscoring, low-molecular weight (≤ 300D) candidates interact well with both the unique and substrate pockets. Cross-docking was used to filter out any compounds that could interact similarly well with the off-target homolog. Thus, a smooth workflow now exists for mining and visualizing conformational population differences between homologs, and applying this information to virtual screening. The top-scoring candidates are chemically diverse while sharing some features: they mimic dihydropterin interactions via an isosteric or alternative ring system, which is connected by a short flexible linker to a second cyclic group binding in the unique pocket of Y pestis HPPK.
Executive Summary
• Molecular dynamics analysis allows identification of conformational sampling differences between homologous proteins that otherwise have very similar binding sites in the closed conformation
• Considering the difference in population of a targeted conformation between two homologs can provide guidance on whether conformational selectivity is a feasible way of enhancing ligand specificity.
• The SpeciFlex protocol allows conformational sampling differences to be identified and exploited during virtual screening. Compounds are identified that can bind well in a substrate pocket and an adjacent selectivity pocket. The compounds are also filtered to remove any that might bind similarly well to the corresponding site in the homolog.
• Steps in the procedure can be substituted by similar methods based upon user preference.
For instance e.g., HREM molecular dynamics using the GROMOS force field could be replaced by CHARMM or AMBER molecular dynamics; SLIDE docking could be substituted by another method suitable for large-scale virtual screening, such as GLIDE; proprietary databases could be used in place of ZINC; and different scoring protocols could be used to rank the candidates. SpeciFlex is essentially a modular protocol in which the emphasis is placed on how to incorporate conformational population differences as a basis for selectivity in virtual screening.
• For the target enzyme HPPK, SpeciFlex filtered more than 800,000 lead-like compounds down to a set of 19 compounds that met the criteria of having high predicted binding affinity and good complementarity with the substrate and unique pocket sites, while exhibiting considerable diversity in chemical structures. Financial & competing interests disclosure. All affiliations with or financial involvement of any organization or entity in the subject matter or materials discussed in the manuscript have been disclosed in the Acknowledgements section. There are no known financial conflicts of organizations or entities with the subject matter or materials. 2. Determine the relative occupancy/availability of regions surrounding the binding site. By placing a 1.4 Å probe at grid points spaced 0.5 Å apart, and calculating van der Waals overlap with the protein in each snapshot of the dynamics trajectories, the probability that a ligand atom could occupy each grid point (percent availability) was determined.
3. Identify pocket volumes that are uniquely available in the target protein, which can then be used for selective inhibitor screening. Grid points that were never accessible (due to presence of protein atoms) in EcHPPK, but that were available in at least 25% of the YpHPPK snapshots were selected. Molecules that occupy these grid points in YpHPPK would incur a small (< 1 kcal/mol) penalty relative to a volume that was 100% available, while not being able to bind similarly to EcHPPK due to occlusion of the site. could never placed at that grid point (0% availability), and yellow, orange, red, and dark red indicates points where probes could be placed 25%, 50%, 75%, and 100% of the time, respectively.
Percentage availability is the complement of percentage occupancy. For example, a grid point that was occupied 25% of the time is considered to be 75% available. Empty grid points at the extreme right edge indicate where a probe could always be placed, and therefore where protein atoms never interacted.
A B Figure 5 . "Russian doll" representation of nested surface shells isocontoured around volumes that were 100% occupied (most central, brightest colored shell; 0% available), 75% occupied (next most central shell), then 50%, 25%, and 0% occupied (outermost shell) over the entire HREM trajectory.
Conformational cluster representatives and the dihydroperin site from Figure 3 
